Search research articles
Contact Us
Filters
Showing results (151-160 of 213) with videos related to
Page
of 22
Sort By:
Journal of the National Cancer Institute
|
May 6, 2024
Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study)
Elisa Fontana, Ezra Rosen, Elizabeth K Lee, et al.
Cell Reports. Medicine
|
December 30, 2020
Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART Molecule
Alexey Berezhnoy, Bradley J Sumrow, Kurt Stahl, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 14, 2023
Prognostic Significance of Percentage and Size of Dedifferentiation in Dedifferentiated Chondrosarcoma
Yin P Hung, Ivan Chebib, Miriam A Bredella, et al.
Investigational New Drugs
|
May 4, 2026
Pooled safety analysis of lurbinectedin plus irinotecan in patients with advanced solid tumors
Alejandro Falcón, Gregory M Cote, Javier Molina-Cerrillo, et al.
Biomedical Microdevices
|
September 27, 2017
Interventional magnetic resonance imaging guided carotid embolectomy using a novel resonant marker catheter: demonstration of preclinical feasibility
Jeffrey K Yang, Andre M Cote, Caroline D Jordan, et al.
Nature Communications
|
August 28, 2024
EWS-WT1 fusion isoforms establish oncogenic programs and therapeutic vulnerabilities in desmoplastic small round cell tumors
Gaylor Boulay, Liliane C Broye, Rui Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2025
Milademetan in advanced solid tumors with MDM2 amplification and wild-type TP53: pre-clinical and phase 2 clinical trial results
Ecaterina E Dumbrava, Thomas E Stinchcombe, Mrinal Gounder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2020
Ivosidenib in Isocitrate Dehydrogenase 1<i>-</i>Mutated Advanced Glioma
Ingo K Mellinghoff, Benjamin M Ellingson, Mehdi Touat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 19, 2023
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)
Matthew Ingham, Jacob B Allred, Li Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2021
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial
Ingo K Mellinghoff, Marta Penas-Prado, Katherine B Peters, et al.
Page
of 22
Search research articles
Search
Showing results (151-160 of 213) with videos related to
Sort By:
Page
of 22
Journal of the National Cancer Institute
|
May 6, 2024
Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study)
Elisa Fontana, Ezra Rosen, Elizabeth K Lee, et al.
Cell Reports. Medicine
|
December 30, 2020
Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART Molecule
Alexey Berezhnoy, Bradley J Sumrow, Kurt Stahl, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 14, 2023
Prognostic Significance of Percentage and Size of Dedifferentiation in Dedifferentiated Chondrosarcoma
Yin P Hung, Ivan Chebib, Miriam A Bredella, et al.
Investigational New Drugs
|
May 4, 2026
Pooled safety analysis of lurbinectedin plus irinotecan in patients with advanced solid tumors
Alejandro Falcón, Gregory M Cote, Javier Molina-Cerrillo, et al.
Biomedical Microdevices
|
September 27, 2017
Interventional magnetic resonance imaging guided carotid embolectomy using a novel resonant marker catheter: demonstration of preclinical feasibility
Jeffrey K Yang, Andre M Cote, Caroline D Jordan, et al.
Nature Communications
|
August 28, 2024
EWS-WT1 fusion isoforms establish oncogenic programs and therapeutic vulnerabilities in desmoplastic small round cell tumors
Gaylor Boulay, Liliane C Broye, Rui Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2025
Milademetan in advanced solid tumors with MDM2 amplification and wild-type TP53: pre-clinical and phase 2 clinical trial results
Ecaterina E Dumbrava, Thomas E Stinchcombe, Mrinal Gounder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2020
Ivosidenib in Isocitrate Dehydrogenase 1<i>-</i>Mutated Advanced Glioma
Ingo K Mellinghoff, Benjamin M Ellingson, Mehdi Touat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 19, 2023
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)
Matthew Ingham, Jacob B Allred, Li Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2021
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial
Ingo K Mellinghoff, Marta Penas-Prado, Katherine B Peters, et al.
Page
of 22